Perspective Therapeutics, Inc. (CATX) Earnings History
Annual and quarterly earnings data from 1994 to 2024
Loading earnings history...
CATX EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
CATX Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | - | - | - |
| 2023 | 100.0% | -2855.0% | -3243.2% |
| 2022 | 23.0% | -213.7% | -206.5% |
| 2021 | 42.8% | -68.5% | -66.3% |
| 2020 | 50.9% | -34.2% | -31.7% |
Download Data
Export CATX earnings history in CSV or JSON format
Free sign-in required to download data
Perspective Therapeutics, Inc. (CATX) Earnings Overview
As of May 8, 2026, Perspective Therapeutics, Inc. (CATX) reported trailing twelve-month net income of -$114M, reflecting -44.7% year-over-year growth. The company earned $-1.61 per diluted share over the past four quarters.
Looking at the long-term picture, CATX's historical earnings data spans multiple years. The company achieved its highest annual net income of $2M in fiscal 1999.
Perspective Therapeutics, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including AGEN ($115,000 net income, 0.1% margin), RNW ($11.97B net income, 3.9% margin), LNTH ($279M net income, 15.2% margin), CATX has comparable earnings metrics. Compare CATX vs AGEN →
CATX Earnings vs Peers
Earnings metrics vs comparable public companies
CATX Historical Earnings Data (1994–2024)
31 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | -$79M | -70.5% | $10M | $-1.23 | - | - |
| 2023 | -$47M | -217.0% | -$41M | $-0.85 | -3243.2% | -2855.0% |
| 2022 | -$15M | -105.1% | -$15M | $-0.27 | -206.5% | -213.7% |
| 2021 | -$7M | -124.4% | -$7M | $-0.13 | -66.3% | -68.5% |
| 2020 | -$3M | +2.5% | -$3M | $-0.06 | -31.7% | -34.2% |
| 2019 | -$3M | +32.6% | -$3M | $-0.05 | -33.8% | -35.9% |
| 2018 | -$5M | +27.6% | -$5M | $-0.07 | -66.3% | -72.2% |
| 2017 | -$7M | -8.7% | -$7M | $-0.12 | -113.1% | -113.6% |
| 2016 | -$6M | -30.8% | -$6M | $-0.11 | -129.4% | -132.5% |
| 2015 | -$5M | -28.0% | -$5M | $-0.09 | -98.8% | -106.6% |
See CATX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CATX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CATX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonCATX — Frequently Asked Questions
Quick answers to the most common questions about buying CATX stock.
Is CATX growing earnings?
CATX EPS fell to $-1.61, with earnings declining -44.7%. This contrasts with the 5-year CAGR of N/A. TTM net income dropped to $-114M.
What are CATX's profit margins?
Perspective Therapeutics, Inc. net margin is N/A, with operating margin at N/A. Below-average margins reflect competitive or cost pressures.
How consistent are CATX's earnings?
CATX earnings data spans 1994-2024. The declining earnings trend is -44.7% YoY. Historical data enables comparison across business cycles.